Vitamin-B3 derivative may cut risk of new skin cancers by 23%

New research indicates taking an oral vitamin-B3 derivative, nicotinamide, may help prevent the recurrence of non-melanoma skin cancers. According to new Australian research, the ONTRAC study, published today in the New England Journal of Medicine, taking an oral vitamin-B3 derivative, nicotinamide, may help prevent non-melanoma skin cancers (NMSCs) in high risk patients. The randomised placebo